BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20096102)

  • 1. Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells.
    Bélanger AS; Tojcic J; Harvey M; Guillemette C
    BMC Mol Biol; 2010 Jan; 11():9. PubMed ID: 20096102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.
    Yasar U; Greenblatt DJ; Guillemette C; Court MH
    J Pharm Pharmacol; 2013 Jun; 65(6):874-83. PubMed ID: 23647681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential fucosyltransferase IV expression in squamous carcinoma cells is regulated by promoter methylation.
    Li H; Tong S; Liu J; Han L; Yang X; Hou H; Yan Q; Wang XQ
    Cell Mol Biol Lett; 2012 Jun; 17(2):206-16. PubMed ID: 22287018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA demethylation and tri-methylation of H3K4 at the TACSTD2 promoter are complementary players for TROP2 regulation in colorectal cancer cells.
    Gehring A; Huebner K; Rani H; Erlenbach-Wuensch K; Merkel S; Mahadevan V; Grutzmann R; Hartmann A; Schneider-Stock R
    Sci Rep; 2024 Feb; 14(1):2683. PubMed ID: 38302503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DNMT1-associated lincRNA DACOR1 reprograms genome-wide DNA methylation in colon cancer.
    Somasundaram S; Forrest ME; Moinova H; Cohen A; Varadan V; LaFramboise T; Markowitz S; Khalil AM
    Clin Epigenetics; 2018 Oct; 10(1):127. PubMed ID: 30348202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoids and Organic Acids Affect Phase II Metabolism based on the Regulation of UGT1A1 Expression and Function.
    Zhang L; Zhang X; Wang C
    Curr Comput Aided Drug Des; 2024 May; ():. PubMed ID: 38766819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes.
    Lu Y; Peng R; Dong L; Xia K; Wu R; Xu S; Wang J
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37889117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrative mathematical model for timing treatment toxicity and Zeitgeber impact in colorectal cancer cells.
    Hesse J; Müller T; Relógio A
    NPJ Syst Biol Appl; 2023 Jun; 9(1):27. PubMed ID: 37353516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism.
    Liu W; Li J; Zhao R; Lu Y; Huang P
    Front Oncol; 2022; 12():1088458. PubMed ID: 36741721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic.
    Wang Q; Shen X; Chen G; Du J
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging targets in cancer drug resistance.
    Kumar S; Kushwaha PP; Gupta S
    Cancer Drug Resist; 2019; 2(2):161-177. PubMed ID: 35582722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated HNF1A expression promotes radiation-resistance via driving PI3K/AKT signaling pathway in esophageal squamous cell carcinoma cells.
    Zou N; Zhang X; Li S; Li Y; Zhao Y; Yang X; Zhu S
    J Cancer; 2021; 12(16):5013-5024. PubMed ID: 34234870
    [No Abstract]   [Full Text] [Related]  

  • 13. Epigenetics and microRNAs in UGT1As.
    Meng CL; Zhao W; Zhong DN
    Hum Genomics; 2021 May; 15(1):30. PubMed ID: 34034810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNF1A regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.
    Fujino S; Miyoshi N; Ito A; Yasui M; Matsuda C; Ohue M; Uemura M; Mizushima T; Doki Y; Eguchi H
    Sci Rep; 2021 May; 11(1):10363. PubMed ID: 33990627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs.
    Tian C; Gao L; Zucker IH
    Free Radic Biol Med; 2021 May; 167():218-231. PubMed ID: 33741451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer.
    Mendes C; Serpa J
    Antioxidants (Basel); 2019 Nov; 8(12):. PubMed ID: 31795465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiology.
    Xiang Y; Sun Y; Yang B; Yang Y; Zhang Y; Yu T; Huang H; Zhang J; Xu H
    J Cell Mol Med; 2019 Dec; 23(12):8381-8391. PubMed ID: 31576674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of insulin in transdifferentiated hepatocyte proliferation and function in serum-free medium.
    Gu C; Li P; Liu W; Zhou Y; Tan WS
    J Cell Mol Med; 2019 Jun; 23(6):4165-4178. PubMed ID: 30950200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy.
    Leary M; Heerboth S; Lapinska K; Sarkar S
    Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30518036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of DNMT1 in differentiated human cells highlights key classes of sensitive genes and an interplay with polycomb repression.
    O'Neill KM; Irwin RE; Mackin SJ; Thursby SJ; Thakur A; Bertens C; Masala L; Loughery JEP; McArt DG; Walsh CP
    Epigenetics Chromatin; 2018 Mar; 11(1):12. PubMed ID: 29598829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.